Kyverna Therapeutics Inc. (NASDAQ: KYTX) started the day on Wednesday, with a price increase of 13.36% at $8.40, before settling in for the price of $7.41 at the close. Taking a more long-term approach, KYTX posted a 52-week range of $6.30-$35.06.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was -37.90%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 96.28%. This publicly-traded company’s shares outstanding now amounts to $43.12 million, simultaneously with a float of $17.64 million. The organization now has a market capitalization sitting at $362.46 million. At the time of writing, stock’s 50-day Moving Average stood at $8.52.
Kyverna Therapeutics Inc. (KYTX) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Kyverna Therapeutics Inc.’s current insider ownership accounts for 59.11%, in contrast to 37.39% institutional ownership. According to the most recent insider trade that took place on Feb 12 ’24, this organization’s 10% Owner bought 253,136 shares at the rate of 22.00, making the entire transaction reach 5,568,992 in total value, affecting insider ownership by 252,553. Preceding that transaction, on Feb 12 ’24, Company’s 10% Owner bought 450,000 for 22.00, making the whole transaction’s value amount to 9,900,000. This particular insider is now the holder of 3,163,868 in total.
Kyverna Therapeutics Inc. (KYTX) Earnings and Revenue Records
Kyverna Therapeutics Inc.’s EPS increase for this current 12-month fiscal period is 96.28% and is forecasted to reach -4.00 in the upcoming year.
Kyverna Therapeutics Inc. (NASDAQ: KYTX) Trading Performance Indicators
Let’s observe the current performance indicators for Kyverna Therapeutics Inc. (KYTX). It’s Quick Ratio in the last reported quarter now stands at 14.86. The Stock has managed to achieve an average true range (ATR) of 0.77.
In the same vein, KYTX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.63, a figure that is expected to reach -0.76 in the next quarter, and analysts are predicting that it will be -4.00 at the market close of one year from today.
Technical Analysis of Kyverna Therapeutics Inc. (KYTX)
If we take a close look at the recent performances of Kyverna Therapeutics Inc. (NASDAQ: KYTX), its last 5-days Average volume was 0.37 million that shows plunge from its year to date volume of 0.52 million. During the previous 9 days, stock’s Stochastic%D was recorded 84.66% While, its Average True Range was 0.70.
Raw Stochastic average of Kyverna Therapeutics Inc. (KYTX) in the period of the previous 100 days is set at 10.75%, which indicates a major fall in contrast to 88.61% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 82.22% that was lower than 113.45% volatility it exhibited in the past 100-days period.
